You are here: Industry Insights > Ajinomoto

News List

Ajinomoto Bio-Pharma Services Expands Fill Finish Capacity americanpharmaceuticalreview
May 25, 2021
Ajinomoto Bio-Pharma Services announced the opening of a high-speed multi-purpose fill finish line in its state-of-the-art commercial manufacturing facility located in San Diego, CA.
Ajinomoto, Bright Peak Enter Immunocytokines Research Pact contractpharma
March 31, 2021
Ajinomoto Bio-Pharma Services, a biopharmaceutical CDMO, and Bright Peak Therapeutics Inc., a biotechnology company developing next gen immunotherapies for cancer and autoimmune disease, have entered a research collaboration and exclusive license ...
AstraZeneca, Aji Bio-Pharma Expand Mfg. Agreement contractpharma
March 31, 2021
Ajinomoto Bio-Pharma Services, a provider of biopharmaceutical contract development and manufacturing services, entered an expanded manufacturing agreement with AstraZeneca to include drug product manufacturing.
Ajinomoto Bio-Pharma, Humanigen Expand Manufacturing Agreement contractpharma
January 28, 2021
Ajinomoto will support fill finish for investigational COVID-19 therapeutic, lenzilumab, nearing completion of phase 3 study.
FDA Approves First Commercial Drug Manufactured via Ajinomoto AJIPHASE Technology americanpharmaceuticalreview
October 12, 2020
Ajinomoto Bio-Pharma Services announced the U.S. Food and Drug Administration (FDA) has approved the first commercial drug manufactured via Ajinomoto Bio-Pharma’s proprietary AJIPHASE® production process.
Ajinomoto Bio-Pharma Completes Acquisition of Granules OmniChem Joint Venture in India americanpharmaceuticalreview
June 03, 2020
Ajinomoto Bio-Pharma Services has completed the acquisition of Granules OmniChem Private Limited, purchasing the remaining 50 percent ownership interest from its joint venture partner, Granules India Limited.
Ajinomoto Bio-Pharma Partners with Humanigen contractpharma
May 28, 2020
Ajinomoto Bio-Pharma Services, a provider of biopharmaceutical contract development and manufacturing services, has entered into a manufacturing agreement with Humanigen Inc., for the fill finish supply of lenzilumab ...
Ajinomoto Bio-Pharma buys Indian API plant from JV partner fiercepharma
September 02, 2019
Ajinomoto Bio-Pharma Services is taking full control of an API manufacturing facility in India as the CDMO continues to bulk up in a market that favors companies that can do it all.
Ajinomoto Appoints VP of Sales & Marketing contractpharma
April 09, 2019
Ajinomoto Bio-Pharma Services has appointed Jean-Baptiste Agnus as vice president of sales and marketing.
Ajinomoto Bio-Pharma Services Announces Capital Expansion to Fuel Growth en-cphi.cn
March 13, 2019
Ajinomoto Bio-Pharma Services ("Aji Bio-Pharma") provided an update on several of its capital projects currently underway in both the United States and Belgium.

Previous page 1 2 Next page